You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 11, Issue 1

March 2018 - 30 articles

Cover Story: Briefly, amyloid β 1–42 (Aβ) binds to the brain insulin receptor (IR) and dysregulates its signalling cascade in the hippocampus and other brain areas, contributing to the development of insulin resistance. In addition, Aβ indirectly modulates IR activation through the phosphorylation of IR substrates 1 (IRS-1) at its inactivation sites. This response would be the consequence of the increase in reactive glia induced by Aβ and the subsequent release of molecules like tumour necrosis factor alpha (TNFα). Decreased IR signalling leads to reduced activation of protein kinase B (PKB/AKT) which influences other pathways like those controlled by glycogen synthase kinase 3β (GSK3β) and the trafficking of the insulin-sensitive glucose transporter type 4 (GLUT4) to the plasma membrane. In conclusion, all these interrelated mechanisms eventually lead to the well-known memory impairment characteristic of Alzheimer’s disease. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (30)

  • Article
  • Open Access
3 Citations
5,796 Views
15 Pages

A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study

  • Francesco Gentile,
  • Marco A. Deriu,
  • Khaled Barakat,
  • Andrea Danani and
  • Jack Tuszynski

16 February 2018

The Toll-Like Receptor 7 (TLR7) is an endosomal membrane receptor involved in the innate immune system response. Its best-known small molecule activators are imidazoquinoline derivatives such as imiquimod (R-837) and resiquimod (R-848). Recently, an...

  • Article
  • Open Access
23 Citations
6,091 Views
15 Pages

Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex

  • Constain H. Salamanca,
  • Cristhian J. Yarce,
  • Yony Roman,
  • Andrés F. Davalos and
  • Gustavo R. Rivera

10 February 2018

Biocompatible polymeric materials with potential to form functional structures in association with different therapeutic molecules have a high potential for biological, medical and pharmaceutical applications. Therefore, the capability of the inclusi...

  • Meeting Report
  • Open Access
1 Citations
7,027 Views
32 Pages

9 February 2018

The third International Electronic Conference on Medicinal Chemistry, organized and sponsored by MDPI AG, publisher, and the journal Pharmaceuticals, took place in November 2017 on the SciForum website (www.sciforum.net/conference/ecmc-3). Around 300...

  • Feature Paper
  • Review
  • Open Access
56 Citations
10,025 Views
18 Pages

Interactions Between Epilepsy and Plasticity

  • José J. Jarero-Basulto,
  • Yadira Gasca-Martínez,
  • Martha C. Rivera-Cervantes,
  • Mónica E. Ureña-Guerrero,
  • Alfredo I. Feria-Velasco and
  • Carlos Beas-Zarate

7 February 2018

Undoubtedly, one of the most interesting topics in the field of neuroscience is the ability of the central nervous system to respond to different stimuli (normal or pathological) by modifying its structure and function, either transiently or permanen...

  • Article
  • Open Access
9 Citations
6,506 Views
11 Pages

6 February 2018

Vitamin E phosphate (VEP) nucleoside prodrugs are designed to bypass two mechanisms of tumor resistance to therapeutic nucleosides: nucleoside transport and kinase downregulation. Certain isoforms of vitamin E (VE) have shown activity against solid a...

  • Review
  • Open Access
61 Citations
11,445 Views
34 Pages

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules

  • Maria João Gouveia,
  • Paul J. Brindley,
  • Fátima Gärtner,
  • José M. Correia da Costa and
  • Nuno Vale

5 February 2018

Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently relies on a single drug, praziquantel, and despite its efficacy against the all schistosome species that parasitize humans, it displays some problematic drawb...

  • Review
  • Open Access
78 Citations
11,140 Views
19 Pages

1 February 2018

Persistence is a phenomenon during which a small fraction of a total bacterial population survives treatment with high concentrations of antibiotics for an extended period of time. In conjunction with biofilms, antibiotic persisters represent a major...

  • Review
  • Open Access
21 Citations
7,385 Views
19 Pages

A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol

  • Salahaden R. Sultan,
  • Sophie A. Millar,
  • Saoirse E. O’Sullivan and
  • Timothy J. England

31 January 2018

∆9-Tetrahydrocannabinol (THC) has complex effects on the cardiovascular system. We aimed to systematically review studies of THC and haemodynamic alterations. PubMed, Medline, and EMBASE were searched for relevant studies. Changes in blood pressure (...

  • Review
  • Open Access
49 Citations
15,384 Views
16 Pages

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia

  • Jaume Folch,
  • Miren Ettcheto,
  • Oriol Busquets,
  • Elena Sánchez-López,
  • Rubén D. Castro-Torres,
  • Ester Verdaguer,
  • Patricia R. Manzine,
  • Saghar Rabiei Poor,
  • María Luisa García and
  • Jordi Olloquequi
  • + 3 authors

29 January 2018

Alzheimer’s disease (AD) is progressive neurodegenerative disorder characterized by brain accumulation of the amyloid β peptide (Aβ), which form senile plaques, neurofibrillary tangles (NFT) and, eventually, neurodegeneration and cognitive impairment...

  • Feature Paper
  • Review
  • Open Access
83 Citations
13,551 Views
19 Pages

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

  • Rafaela Peron,
  • Izabela Pereira Vatanabe,
  • Patricia Regina Manzine,
  • Antoni Camins and
  • Márcia Regina Cominetti

29 January 2018

ADAM (a disintegrin and metalloproteinase) is a family of widely expressed, transmembrane and secreted proteins of approximately 750 amino acids in length with functions in cell adhesion and proteolytic processing of the ectodomains of diverse cell-s...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247